241 related articles for article (PubMed ID: 17216701)
1. Neurological complications of infliximab.
Tektonidou MG
J Rheumatol; 2007 Jan; 34(1):237; author reply 237-8. PubMed ID: 17216701
[No Abstract] [Full Text] [Related]
2. Neurological complications of infliximab.
Roos JC; Ostor AJ
J Rheumatol; 2007 Jan; 34(1):236-7; author reply 237-8. PubMed ID: 17216699
[No Abstract] [Full Text] [Related]
3. Neurological complications of infliximab.
Jarand J; Zochodne DW; Martin LO; Voll C
J Rheumatol; 2006 May; 33(5):1018-20. PubMed ID: 16511935
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alpha blocker induced tuberculosis.
Kharbanda P; Dagaonkar R; Balakrishnan C; Udwadia ZF
J Rheumatol; 2010 Jul; 37(7):1542; author reply 1543. PubMed ID: 20595292
[No Abstract] [Full Text] [Related]
5. Infection and anti-tumor necrosis factor-alpha therapy.
Zandman-Goddard G
Isr Med Assoc J; 2003 Nov; 5(11):814-6. PubMed ID: 14650109
[No Abstract] [Full Text] [Related]
6. Successful rechallenge with anti-tumor necrosis factor alpha for psoriatic arthritis after development of demyelinating nervous system disease during initial treatment: comment on the article by Mohan et al.
Cisternas M; Gutiérrez M; Jacobelli S
Arthritis Rheum; 2002 Nov; 46(11):3107-8; author reply 3108-9. PubMed ID: 12428265
[No Abstract] [Full Text] [Related]
7. [Indications and adverse events with the use of anti-TNFalpha agents in pediatric rheumatology: experience of a single center].
de Oliveira SK; de Almeida RG; Fonseca AR; Rodrigues MC; Sztajnbok F; Diniz C
Acta Reumatol Port; 2007; 32(2):139-50. PubMed ID: 17572652
[TBL] [Abstract][Full Text] [Related]
8. Multifocal motor neuropathy with conduction block in a patient with rheumatoid arthritis on infliximab therapy.
Rodriguez-Escalera C; Belzunegui J; Lopez-Dominguez L; Gonzalez C; Figueroa M
Rheumatology (Oxford); 2005 Jan; 44(1):132-3. PubMed ID: 15611308
[No Abstract] [Full Text] [Related]
9. Rheumatoid vasculitis treated with infliximab.
van der Bijl AE; Allaart CF; Van Vugt J; Van Duinen S; Breedveld FC
J Rheumatol; 2005 Aug; 32(8):1607-9. PubMed ID: 16078342
[TBL] [Abstract][Full Text] [Related]
10. Introduction to special section: biologic agents in the treatment of rheumatic diseases-the first decade.
Yelin E; Katz P
Arthritis Rheum; 2009 May; 61(5):559. PubMed ID: 19405010
[No Abstract] [Full Text] [Related]
11. Biological therapy and neurological manifestations. What do we know?
Tejera-Segura B; Ferraz-Amaro I
Reumatol Clin; 2017; 13(2):102-106. PubMed ID: 27373584
[TBL] [Abstract][Full Text] [Related]
12. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
Chan CY; Browning JC; Larsen F; Hsu S
Dermatol Online J; 2008 Sep; 14(9):12. PubMed ID: 19061594
[TBL] [Abstract][Full Text] [Related]
13. Cryptococcal meningitis in a patient treated with infliximab.
Muñoz P; Giannella M; Valerio M; Soria T; Díaz F; Longo JL; Bouza E
Diagn Microbiol Infect Dis; 2007 Apr; 57(4):443-6. PubMed ID: 17240111
[TBL] [Abstract][Full Text] [Related]
14. Acute motor and sensory axonal neuropathy and concomitant encephalopathy during tumor necrosis factor-alpha antagonist therapy.
Faivre A; Franques J; De Paula AM; Gutierrez M; Bret S; Aubert S; Attarian S; Pouget J
J Neurol Sci; 2010 Apr; 291(1-2):103-6. PubMed ID: 20116808
[TBL] [Abstract][Full Text] [Related]
15. Demyelinating disease in a patient with psoriatic arthritis and family history of multiple sclerosis treated with infliximab.
Ruiz-Jimeno T; Carvajal A; Mata C; Aurrecoechea E
J Rheumatol; 2006 Jul; 33(7):1457-8. PubMed ID: 16862660
[No Abstract] [Full Text] [Related]
16. [Non-TNF biologicals in therapy].
Wollenhaupt J; Burmester GR
Z Rheumatol; 2010 Sep; 69(7):579-80. PubMed ID: 20703491
[No Abstract] [Full Text] [Related]
17. TNF-alpha antagonists: pulmonary legionellosis.
Prescrire Int; 2007 Feb; 16(87):20. PubMed ID: 17326282
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumour necrosis factor agents and lipid profile: a class effect?
Garcês SP; Parreira Santos MJ; Vinagre FM; Roque RM; da Silva JA
Ann Rheum Dis; 2008 Jun; 67(6):895-6. PubMed ID: 18474660
[No Abstract] [Full Text] [Related]
19. Development of leprosy and type 1 leprosy reactions after treatment with infliximab: a report of 2 cases.
Scollard DM; Joyce MP; Gillis TP
Clin Infect Dis; 2006 Jul; 43(2):e19-22. PubMed ID: 16779736
[TBL] [Abstract][Full Text] [Related]
20. Interstitial pneumonitis and anti-tumor necrosis factor-alpha therapy.
Roos JC; Chilvers ER; Ostor AJ
J Rheumatol; 2007 Jan; 34(1):238-9; author reply 239. PubMed ID: 17216703
[No Abstract] [Full Text] [Related]
[Next] [New Search]
